Back to results
US 2014/0271814 A1Published application
Cell binding peptide drug delivery system and compound for treating cancer and tumors
OwnerShiva Andraliinventor
Life of this patent
Estimating the term…
Abstract
The present invention is a method and compound for treating cancer and tumors. The invention treats cancer by encapsulating certain cancer fighting drugs in a liposome. Peptides attached to the compound then guide the compound towards its target. During its journey, DSPE-PEG is used to stabilize the compound, to allow more time in the blood stream before losing effectiveness.
Claims17
A cancer treatment compound comprising:
- one or more therapeutic agents in an amount of from 9.0 to 50.0 percent by weight based on a total weight of said cancer fighting compound;
- a liposome component in an amount of from 38.0 to 70.0 percent by weight based on a total weight of said cancer fighting compound.
A cancer treatment compound comprising:
- one or more therapeutic agents in an amount of from 8.0 to 48.0 percent by weight based on a total weight of said cancer fighting compound;
- a liposome component in an amount of from 34.0 to 63.0 percent by weight based on a total weight of said cancer fighting compound;
- a peptides component in an amount of from 8.0 to 16.0 percent by weight based on a total weight of said cancer fighting compound;
- a DSPE-PEG component in an amount of from 12.0 to 21.0 percent by weight based on a total weight of said cancer fighting compound;
- wherein said one or more therapeutic agents is selected from one or more of the following classes:
- anti-neoplastic therapeutic agents, non-steroidal anti-inflammatory therapeutic agents, steroidal anti-inflammatory therapeutic agents, nucleic acid or nucleotide sequence for non-viral gene therapy, hormones, peptides, growth factors, antiangiogenic compounds, antisense oligonucleotides, anti-micro RNA molecules, microRNA molecules, herbal drugs, and antibodies;
- wherein said peptides component is a Collagen binding peptide;
- wherein said one or more cancer fighting drugs is encapsulated in said liposome component;
- wherein said liposome component comprises a phospholipid bilayer;
- wherein said peptides component attach to said liposome component, and causes said cancer treatment compound to preferentially bind to tumors;
- wherein said cancer treatment compound releases said one or more cancer fighting drugs upon binding with cancerous cells and tumors;
- wherein said DSPE-PEG component is attached to said peptide component, and stabilizes said cancer treatment compound to allow said cancer treatment compound to spend more time in a bloodstream before becoming less effective.
9 more elements
Dependencies are inferred from the claim text.